pharma

YOU MIGHT BE INTERESTED IN

Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021
What are the commercial prospects for lyophilisation technology? Our new report shows you potential revenues to 2021. Our report covers lyophilisation (cryodesiccation or freeze drying) in pharmaceutical applications: technologies, products and services. You will assess events, opportunities and activities shaping the lyophilisation industry and market from 2011 to 2021.
...more details
Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025
The market for pre-filled syringes has achieved growth in recent years. In 2009, an estimated 2 billion pre-filled syringe units were sold and the market for that technology was estimated to be worth up to $2.5 billion. There is a trend towards pre-filled drug injection systems, away from vials/ampules, for both new and existing products. Examples are filled glass and plastic syringes, pens and low-volume auto-injection devices, including refills. That sector has shown growth of 10-15% in recent years, forming one of the fastest-expanding sectors in the pharmaceutical industry. In our new report, we predict that the pre-filled drug delivery market will grow steadily from 2010, as the number of products launched in pre-filled injectable forms increases.
...more details
Biobanking for Medical R&D: Technology and Market 2010-2025
Biobanking for Medical R&D: Technology and Market 2010-2025 reveals the opportunities and challenges the biobanking sector will face. These include consolidation and harmonisation of biobanking practices. Advances in genetic research, stem cell research and regenerative medicine increase the importance of biobanking, as well as its commercial potential.
...more details
Global Vaccines Market 2010-2025
In 2009, the global market for vaccines achieved sales of over $10bn. Hundreds of millions of people are affected by infectious diseases that can be fought by vaccination. Despite controversy, vaccine use remains one of the greatest successes in the fight against disease - one with a long history. This market will achieve sustained growth over the next 15 years, our new study reveals. Increasingly, governments recognise the benefits of mass vaccination, with successive vaccines delivering healthcare solutions on a large scale, a trend set to continue.
...more details
Influenza Vaccine Market Outlook 2010-2020
The influenza vaccines market is one of the fastest-growing sectors of the global pharmaceutical industry, generating multi-billion dollar revenues currently. The re-emergence of influenza as a pandemic threat this decade has stimulated this market area greatly, with vaccines coming back to the fore in healthcare worldwide. Our new pharma report - Influenza Vaccine Market Outlook 2010-2020 - explains how that market area will develop and where the main commercial opportunities will lie.
...more details
Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025
Our new report will show you how the industry and market for vaccines manufacturing will develop. You can indentify where the greatest opportunities will lie for human-use vaccines. There will be trends to watch from 2010 onwards, with areas of revenue growth. You can have our report today, staying ahead. Which vaccines manufacturing segments will grow fastest from 2010? What are the commercial trends to watch? How will leading companies perform? We aim to save you time and benefit your work.
...more details
Drug Delivery Technologies: Commercial Prospects 2010-2025
How will the drug delivery sector develop from 2010, and where will you find the greatest opportunities? How will technology suppliers and drug companies benefit? We show you opportunities for revenue growth for suppliers and users of drug delivery technologies. You can have our report today, staying ahead.
...more details

REPORT

...see all

Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025

Download report Download sample

Publication date: 28/06/2010
Number of Pages: 121

Report Details
Table of Contents
Companies Listed

Report Details

- how will rising demand and technological developments create opportunities?

Lyophilisation (also known as freeze drying or cryodesiccation) is an operation used for the preparation of stable pharmaceutical products. The market for lyophilisation has enjoyed strong growth in recent years, driven by new products and drug classes, especially in biotechnology. In recent years, the number of such products has been growing steadily. It is predicted that half of the injectable drugs approved in the next five years will require lyophilisation. In our new report, we predict that the global lyophilisation market will grow steadily in revenue and unit sales from 2010 to 2025.

Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025 shows how the sector will be driven by the introduction of new products, particularly monoclonal antibodies (MAbs) and other proteins. There will also be developments in drying and packaging technologies. Products benefiting from lyophilisation technology include:
• Active pharmaceutical ingredients (API)
• Vaccines
• Diagnostic kits
• Reagents
• Proteins
• Hormones
• Viral preparations
• Bacterial preparations
• Tissue preparations
• Blood plasma products
• Enzymes
• Pathological samples
• Nutraceuticals
• Vitamins
• Herbal extracts.

There is an increased demand from pharmaceutical companies for manufacturing equipment and services for lyophilisation. As a result, the lyophilisation sector is one of the fastest growing in the global healthcare industry. All the therapeutic segments using lyophilisation have been expanding, but which will grow fastest in years to come? What are the main therapeutic and commercial trends to watch? How will the worldwide market for freeze-drying technology and services perform from 2010 to 2025? Our new report answers questions such as those, providing the information that you need.

Our report shows how the lyophilisation market will experience strong revenue growth from 2010 to 2025, with greater demand for injectable drugs and vaccines requiring drying technologies. There are under-met needs for improved stability and cost effectiveness, as well as for more convenience in transport, storage and use of therapeutic agents. Rapid stabilisation, long-term product stability, ease of reconstitution and process advantages for heat-sensitive products will drive growth of the lyophilisation technology and services market. From 2010 onwards, there will be developments in freeze-drying technology that will benefit the sector and its customers, extending performance and applications.

Detailed analysis of the lyophilisation industry and market

Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025 examines that sector through a comprehensive review of information sources, primary and secondary. This report provides our sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis. There are over 70 tables and figures included and an interview with an industry expert. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025

This report gives you the following benefits in particular:
• You will receive a comprehensive analysis of the prospects for lyophilisation products and services, including predicted revenues and other data, by overall market and main subgroup/application
• You will find out how the lyophilisation industry and market will change from 2010 to 2025, with sales forecasts for the global market and leading national markets (US, Japan, UK, Germany, France, Spain, Italy, China and India)
• You will discover the prospects for relevant therapeutic classes, with forecasts and other data for 2010 to 2025
• You will discover how the lyophilisation products and services sector is evolving to deliver improved ease of use, safety, product stability and convenience of transport/storage
• You will analyse the drivers, restraints, competition and opportunities influencing the lyophilisation product and service industries and markets
• You will receive expert views from our survey, including an interview transcript
• You will investigate developments in that sector – technological and commercial – with the most exciting trends and opportunities highlighted.

You can obtain this report today

Nobody with an interest in drug packaging, drug delivery and pharmaceutical biotechnology should overlook our new study. Success from 2010 onwards will be characterised by greater product stability and more-convenient presentation of high-value pharmaceuticals, with the lyophilisation sector benefiting. Rising healthcare demands – coupled with benefits to pharma stakeholders – are drivers of this market. Do you want to harness those opportunities? You can stay ahead by ordering this report today.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Executive Summary
1.1 Lyophilisation Market Review
1.2 Aims, Scope and Format of the Report
1.3 Research & Analysis Methods

2. Introduction to Lyophilisation (Freeze Drying)
2.1 Introduction
2.1.1 What is Freeze Drying?
2.1.2 Why Freeze Dry?
2.1.3 A Brief History
2.2 General Description of the Process
2.2.1 Freezing
2.2.2 Primary Drying (Sublimation)
2.2.3 Secondary Drying (Desorption)
2.2.4 Freeze Drying Equipment
2.2.4.1 Components of the Freeze Drier
2.2.4.1.1 Drying Chamber
2.2.4.1.2 Condenser
2.2.4.1.3 Vacuum Pump
2.2.4.1.4 Refrigeration System
2.2.4.1.5 Control Facilities
2.2.4.2 Rotary Freeze Dryers
2.2.4.3 Manifold Freeze Dryers
2.2.4.4 Tray Freeze Dryers
2.3 Applications of Lyophilisation
2.3.1 Pharmaceutical and Biotechnology Industry
2.3.2 Other Chemical and Technological Sectors
2.3.3 Veterinary Applications
2.3.4 Food Industry Applications
2.3.4.1 What Products are Freeze Dried?
2.3.4.2 How do Freeze Dryers for Food Differ from those for Pharmaceutical Applications?
2.3.5 Other Applications for Lyophilisation

3. Leading National Markets for Lyophilisation
3.1 The World Lyophilisation Technology Market in 2010
3.2 Growing Market for Lyophilisation Technology and Services
3.2.1 Sales Forecast for Overall Lyophilisation Market, 2010-2016
3.2.2 Sales Forecast for Overall Lyophilisation Market, 2017-2025
3.3 Breakdown of the Global Lyophilisation Market
3.3.1 Sales Forecast for cGMP Lyophilisers, 2010-2016
3.3.2 Sales Forecast for cGMP Lyophilisers, 2017-2025
3.3.3 Sales Forecast for Laboratory Lyophilisers, 2010-2016
3.3.4 Sales Forecast for Laboratory Lyophilisers, 2017-2025
3.3.5 Sales Forecast for Lyophilisation Services, 2010-2016
3.3.6 Sales Forecast for Lyophilisation Services, 2017-2025
3.4 Leading National Markets for Lyophilisation Technology, 2010-2025
3.4.1 Leading National Markets for Lyophilisation Technology, 2010-2025
3.4.2 The Japanese Lyophilisation Technology Market, 2010-2025
3.4.3 The Leading European Lyophilisation Technology Markets, 2010-2025
3.4.4 Emerging Economy Lyophilisation Technology Markets
3.4.5 The Chinese Lyophilisation Technology Market, 2010-2025
3.4.6 The Indian Lyophilisation Technology Market, 2010-2025

4. Worldwide Market for Lyophilised Products and Technology
4.1 Therapeutic Areas Offering Growth Opportunities
4.1.1 The Leading Biotech Therapy Classes, 2010-2025
4.1.2 The Top 10 Biotech Therapy Classes in 2009
4.1.3 The Oncology Class Currently Leads the Biotech Market
4.1.3.1 Long-Term Prospects in Oncology & Implications for Lyophilisation Market
4.1.4 The Human Insulins Class will Exhibit Strong Growth
4.1.5 Immunosuppressive Agents, 2010-2025
4.1.6 Autoimmune Agents Show Promising Growth - Will it Last?
4.1.7 Erythropoietin Products - How will Reported Safety Affect Sales?
4.1.7.1 Erythropoietin Products Forecast, 2010-2025
4.1.8 Immunostimulating Agents - Sales Prospects
4.1.9 The Interferons Class will Show an Increase in Revenues from 2010-2015
4.1.9.1 Long-Term Forecast for the Interferons Class
4.1.10 Will Pure Vaccine Sales Continue to Decline After 2015?
4.1.10.1 Will Pure Vaccines Sales Continue to Decline after 2015?
4.1.11 Blood Coagulation Factors will Show Steady Growth
4.1.12 Growth Hormones Forecast, 2010-2025
4.2 Summary of World Market Forecasts
4.2.1 The Top 10 Biotech Therapy Classes, 2010-2025
4.2.2 Lyophilisation Market: a Rapidly Expanding Segment of the Global Pharma Sector

5. Some Prominent Companies in the Lyophilisation Industry and Market
5.1 Introduction
5.2 GEA Lyophil
5.2.1 Overview
5.2.2 Capabilities of GEA Lyophil
5.2.3 Lyophilisation Production Systems
5.2.4 GEA Lyophil's Fast Track Project Management
5.2.5 GEA's Thermodynamic Lyophilisation Control
5.2.6 GEA's Retrofits of Lyophilisers
5.2.7 GEA's VAPOVAC: Technology for Freeze Dryer Sterilisation
5.2.8 GEA's Lyovac Production Lyophilisers
5.2.9 GEA Lyophil's Pilot Freeze Dryers
5.2.10 ALUS: GEA Lyophil's Automatic Loading and Unloading Systems for Lyophilisers
5.2.11 GEA Lyophil's Research and Development Freeze Dryers
5.3 Labconco Corporation
5.3.1 Overview
5.3.2 Global Presence
5.3.3 Product Focus
5.3.3.1 Freeze Dry Systems
5.3.3.2 Dry Ice Bench-top Freeze Dry System
5.3.3.3 FreeZone Bench-top Freeze Dry Systems
5.3.3.4 FreeZone Console Freeze Dry Systems
5.3.3.5 FreeZone Cascade Freeze Dry Systems
5.3.3.6 FreeZone Triad Freeze Dry Systems
5.3.4 Labconco Freeze Dry Accessories
5.3.5 R&D
5.3.6 Future Outlook
5.4 Vetter Pharma-Fertigung
5.4.1 Overview
5.4.2 Global Presence
5.4.3 Business Interests
5.4.3.1 Vetter Development Service
5.4.3.2 Vetter Commercial Manufacturing
5.4.3.3 Vetter Solutions
5.4.4 Capabilities
5.4.5 R&D
5.4.6 Product Focus
5.4.6.1 Dual-Chamber Technology
5.4.7 Future Outlook
5.5 Piramal Healthcare
5.5.1 Overview
5.5.2 Piramal's Corporate Restructuring
5.5.3 Therapeutic Interests
5.5.4 Global Presence
5.5.5 Strengths & Capabilities

6. SWOT Analysis of the Lyophilisation Technology Market
6.1 Introduction
6.2 Commercial Drivers of the Lyophilisation Technology Market
6.3 Commercial Restraints for the Lyophilisation Technology Market
6.3.1 High Entry Barriers to Sector
6.3.2 Product Formulation Challenges
6.3.3 R&D Stage for Lyophilised Products
6.3.4 Scale-up Stage for Lyophilised Products
6.3.5 Large Scale Production Stage for Lyophilised Products
6.3.6 Main Challenges in a Freeze-Drying Plant
6.3.7 Main Issues in Production
6.3.8 Typical Deficiencies in a Freeze-Drying Process
6.4 Challenges Facing the Lyophilisation Technology Industry and Market
6.4.1 Spray Drying of Biopharmaceuticals
6.4.2 Other Methods in Development
6.4.3 Roche's Precipitation Method
6.5 Expert Interview: Dr Steven Nail, Baxter Healthcare, USA
6.5.1 Current Market Worth for Freeze-drying
6.5.2 Products Suitable for Lyophilisation
6.5.3 Percentage of Lyophilised Products on Market
6.5.4 Key Areas for Research and Development
6.5.5 On Advantages of Lyophilisation
6.5.6 On Advantages of Lyophilisation over Other Drug Delivery Systems
6.5.7 On Drawbacks of Lyophilisation over Other Technologies
6.5.8 On Novel Technologies and Developments
6.6 Summary

7. Conclusions: Lyophilisation Technology and Services are a Growth Market
7.1 Overview
7.2 Prominent Companies in the Market
7.3 Commercial Drivers of the Lyophilisation Market
7.4 Future Outlook and Concluding Remarks

Lists of Tables
Table 3.1 Lyophilisation Technology and Services: World Sales Forecast, 2010-2016
Table 3.2 Lyophilisation Technology and Services: World Sales Forecast, 2017-2025
Table 3.3 cGMP Lyophilisers: World Sales Forecast, 2010-2016
Table 3.4 cGMP Lyophilisers: World Sales Forecast, 2017-2025
Table 3.5 Laboratory Lyophilisers: World Sales Forecast, 2010-2016
Table 3.6 Laboratory Lyophilisers: World Sales Forecast, 2017-2025
Table 3.7 Lyophilisation Services Market: World Sales Forecast, 2010-2016
Table 3.8 Lyophilisation Services Market: World Sales Forecast, 2017-2025
Table 3.9 Lyophilisation Market: World Sales Forecast, 2010-2016
Table 3.10 Lyophilisation Market: World Sales Forecast, 2017-2025
Table 3.11 Leading Lyophilisation National Market Forecasts, 2010-2015, 2020 & 2025
Table 4.1 The Top 10 Biotech Therapy Classes, 2009
Table 4.2 Oncology Class: World Sales Forecast, 2010-2016
Table 4.3 Oncology Class: World Sales Forecast, 2017-2025
Table 4.4 Human Insulins Class: World Sales Forecast, 2010-2016
Table 4.5 Human Insulins Class: World Sales Forecast, 2017-2025
Table 4.6 Immunosuppressive Agents Class: World Sales Forecast, 2010-2016
Table 4.7 Immunosuppressive Agents Class: World Sales Forecast, 2017-2025
Table 4.8 Autoimmune Agents Class: World Sales Forecast, 2010-2016
Table 4.9 Autoimmune Agents Class: World Sales Forecast, 2017-2025
Table 4.10 Erythropoietin Products Class: World Sales Forecast, 2010-2016
Table 4.11 Erythropoietin Products Class: World Sales Forecast, 2017-2025
Table 4.12 Immunostimulating Agents Class: World Sales Forecast, 2010-2016
Table 4.13 Immunostimulating Agents Class: World Sales Forecast, 2017-2025
Table 4.14 Interferons Class: World Sales Forecast, 2010-2016
Table 4.15 Interferons Class: World Sales Forecast, 2017-2025
Table 4.16 Pure Vaccines Class: World Sales Forecast, 2010-2016
Table 4.17 Pure Vaccines Class: World Sales Forecast, 2017-2025
Table 4.18 Blood Coagulation Factors Class: World Sales Forecast, 2010-2016
Table 4.19 Blood Coagulation Factors Class: World Sales Forecast, 2017-2025
Table 4.20 Growth Hormones Class: World Sales Forecast, 2010-2016
Table 4.21 Growth Hormones Class: World Sales Forecast, 2017-2025
Table 4.22 Leading Biotech Therapy Classes: World Sales Forecasts, 2010-2016
Table 4.23 Leading Biotech Therapy Classes: World Sales Forecasts, 2017-2025
Table 5.1 GEA Pharma Systems: A Historical Perspective
Table 5.2 Labconco: A Brief History
Table 5.3 Leading Companies in the Lyophilisation Market, 2010
Table 6.1 SWOT Analysis for the Lyophilisation Sector: Strengths and Weaknesses, 2010-2025
Table 6.2 SWOT Analysis for the Lyophilisation Sector: Opportunities and Threats, 2010-2025
Table 6.3 Advantages of a Spray Dryer for Drying Applications, 2010
Table 6.4 Comparison of Lyophilisation and Spray Drying, 2010
Table 7.1 Lyophilisation Market: World Sales Forecast, 2010, 2012, 2015, 2018, 2020 and 2025

Lists of Figures
Figure 2.1 The Freeze Drying Process
Figure 2.2 Components of a Typical Freeze Dryer
Figure 2.3 Typical Lyophilisation (Freeze Drying) Process
Figure 3.1 Lyophilisation Technology and Services: World Sales Forecast, 2010-2016
Figure 3.2 Lyophilisation Technology and Services: World Sales Forecast, 2017-2025
Figure 3.3 cGMP Lyophilisers: World Sales Forecast, 2010-2016
Figure 3.4 cGMP Lyophilisers: World Sales Forecast, 2017-2025
Figure 3.5 Laboratory Lyophilisers: World Sales Forecast, 2010-2016
Figure 3.6 Laboratory Lyophilisers: World Sales Forecast, 2017-2025
Figure 3.7 Lyophilisation Services Market: World Sales Forecast, 2010-2016
Figure 3.8 Lyophilisation Services Market: World Sales Forecast, 2017-2025
Figure 3.9 Lyophilisation Market: World Sales Forecast, 2010-2025
Figure 3.10 US Lyophilisation Market: Sales Forecast, 2010-2025
Figure 3.11 Other Leading Lyophilisation National Markets: Sales Forecasts, 2010-2025
Figure 3.12 Lyophilisation Sales Shares in Leading National Markets, 2010
Figure 3.13 Lyophilisation Sales Shares in Leading National Markets, 2015
Figure 3.14 Lyophilisation Sales Shares in Leading National Markets, 2020
Figure 3.15 Lyophilisation Sales Shares in Leading National Markets, 2025
Figure 4.1 Oncology Class: World Sales Forecast, 2010-2025
Figure 4.2 Human Insulins Class: World Sales Forecast, 2010-2025
Figure 4.3 Immunosuppressive Agents Class: World Sales Forecast, 2010-2025
Figure 4.4 Autoimmune Agents Class: World Sales Forecast, 2010-2025
Figure 4.5 Erythropoietin Products Class: World Sales Forecast, 2010-2025
Figure 4.6 Immunostimulating Agents Class: World Sales Forecast, 2010-2025
Figure 4.7 Interferons Class: World Sales Forecast, 2010-2025
Figure 4.8 Pure Vaccines Class: World Sales Forecast, 2010-2025
Figure 4.9 Blood Coagulation Factors Class: World Sales Forecast, 2010-2025
Figure 4.10 Growth Hormones Class: World Sales Forecast, 2010-2025
Figure 4.11 Leading Biotech Therapy Classes: World Sales Forecast, 2010-2025
Figure 4.12 Top Ten Therapy Classes: World Sales, 2009, 2015 & 2025
Figure 7.1 Lyophilisation Market: World Sales Forecast, 2010-2025

Companies Listed

AAIPharma Services
ABC Laboratories
Allergan
Almac
Althea Technologies
Azopharma Product Development Group
Baxter Healthcare
B. Braun Melsungen
Ben Venue Laboratories
Bilcare Global Clinical Supplies, Americas
Biopharma Process Systems
Biopharma Technology
Cangene Biopharma
Catalent Pharma Solutions
CMC Biologics
Coldstream Laboratories
DSM Pharmaceuticals
European Medicines Agency (EMEA)
Food and Drug Administration (US FDA)
Formatech
Freezedry Specialties
Fresenius Kabi Product Partnering
FTS Systems
Galenix
GEA Lyophil (GEA Pharma Systems, GEA Group)
Genentech
Girindus America
Gland Pharma
GP Pharm
Grand River Aseptic Pharmaceutical Packaging
Haemtech Biopharma Services
Haupt Pharma
HollisterStier Contract Manufacturing
Hospira One 2 One
Hovione
Huapont Pharm. Co.
Hyaluron Contract Manufacturing (HCM)
IDT Biologika
IMA Edwards Pharmaceutical Systems
Impact Analytical
Intas Biopharmaceuticals
Irvine Pharmaceutical Services
JHP Pharmaceuticals
Jouan Nordic
KBI Biopharma
King Pharmaceuticals
KP Pharmaceutical Technology
Lab. PiSA
Labconco Corporation
Lampire Biological Laboratories
Legacy Pharmaceuticals International
Lonza
Lyophilisation Services of New England (LSNE)
Lyophilisation Technology
Martin Christ Gefriertrocknungsanlagen
MedPharm
Miltenyi Biotec, Bioprocess Division
Ministry of Health, Labour and Welfare (Japan)
Molecular Profiles
National Archives and Records Administration (NARA), Document Conservation Laboratory (DCL)
Nextar Chempharma Solutions (formerly Aminolab Pharma)
NextPharma
Nicholas Piramal
Niro
Nycomed
Oakwood Laboratories
OctoPlus
Om Bhagwati Labelling Technologies
Omnia Biologics
One 2 One Global Pharmaceutical Services (Hospira)
Optima Machinery Corporation
Oregon Freeze Dry
Oso BioPharmaceutical Manufacturing
Overlook Industries
Patheon
Pfizer CentreSource
Pharmatek Laboratories
Piramal Healthcare
PolyPeptide Laboratories
Quality Assistance
Rana Diagnostics
Reig Jofré Group
RFCL
Richman Chemical
Roche
SAFC Pharma
Sandoz (part of Novartis)
Scripps Laboratories
Serail Freeze-Drying Systems
SL Pharma Labs
Solvay
SP Formulations
SP Industries
SRI International
Stason Pharmaceuticals.
Therapure Biopharma
Thermo Fisher Scientific
University of Iowa Pharmaceuticals (UIP)
USIFROID
Vectech
Vetter Pharma International
Vetter Pharma-Fertigung
Walter Reed Pilot Bioproduction Facility

YOU MIGHT BE INTERESTED IN

Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021

Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025

Biobanking for Medical R&D: Technology and Market 2010-2025

Global Vaccines Market 2010-2025

Influenza Vaccine Market Outlook 2010-2020

Vaccines Manufacturing Technology and Services: Commercial Prospects 2010-2025

Drug Delivery Technologies: Commercial Prospects 2010-2025

REPORT

Lyophilisation for Pharmaceuticals: Technology and Market 2010-2025

Report Details

Table of Contents

Companies Listed